Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers.

ISRN Pharmaceutics Pub Date : 2011-01-01 Epub Date: 2011-09-05 DOI:10.5402/2011/819765
Abhisekh Das, Amit Kumar Nayak, Biswaranjan Mohanty, Satyabrata Panda
{"title":"Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers.","authors":"Abhisekh Das,&nbsp;Amit Kumar Nayak,&nbsp;Biswaranjan Mohanty,&nbsp;Satyabrata Panda","doi":"10.5402/2011/819765","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of the present study was to improve solubility and dissolution of the poorly aqueous soluble drug, etoricoxib by solvent evaporation technique using various sugar carriers, such as lactose, sucrose, and mannitol. Etoricoxib solid dispersions and their respective physical mixtures using lactose, sucrose, and mannitol were prepared in different ratios by solvent evaporation technique. The percent yield, drug content, saturation solubility, and in vitro dissolution of etoricoxib solid dispersions and physical mixtures were analyzed. Etoricoxib solid dispersions were characterized by FTIR spectroscopy, XRD, and DSC analysis. The FTIR spectroscopic analysis revealed the possibility of intermolecular hydrogen bonding in various solid dispersions. The XRD and DSC studies indicated the transformation of crystalline etoricoxib (in pure drug) to amorphous etoricoxib (in solid dispersions) by the solid dispersion technology. Both the aqueous solubility and dissolution of etoricoxib were observed in all etoricoxib solid dispersions as compared with pure etoricoxib and their physical mixtures. The in vitro dissolution studies exhibited improved dissolution in case of solid dispersion using lactose than the solid dispersions using both sucrose and mannitol. The in vitro dissolution of etoricoxib from these solid dispersions followed Hixson-Crowell model.</p>","PeriodicalId":14802,"journal":{"name":"ISRN Pharmaceutics","volume":"2011 ","pages":"819765"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/819765","citationCount":"54","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2011/819765","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2011/9/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 54

Abstract

The aim of the present study was to improve solubility and dissolution of the poorly aqueous soluble drug, etoricoxib by solvent evaporation technique using various sugar carriers, such as lactose, sucrose, and mannitol. Etoricoxib solid dispersions and their respective physical mixtures using lactose, sucrose, and mannitol were prepared in different ratios by solvent evaporation technique. The percent yield, drug content, saturation solubility, and in vitro dissolution of etoricoxib solid dispersions and physical mixtures were analyzed. Etoricoxib solid dispersions were characterized by FTIR spectroscopy, XRD, and DSC analysis. The FTIR spectroscopic analysis revealed the possibility of intermolecular hydrogen bonding in various solid dispersions. The XRD and DSC studies indicated the transformation of crystalline etoricoxib (in pure drug) to amorphous etoricoxib (in solid dispersions) by the solid dispersion technology. Both the aqueous solubility and dissolution of etoricoxib were observed in all etoricoxib solid dispersions as compared with pure etoricoxib and their physical mixtures. The in vitro dissolution studies exhibited improved dissolution in case of solid dispersion using lactose than the solid dispersions using both sucrose and mannitol. The in vitro dissolution of etoricoxib from these solid dispersions followed Hixson-Crowell model.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
糖载体固体分散技术增强依托昔布的溶解度和溶出度。
本研究的目的是利用不同的糖载体,如乳糖、蔗糖和甘露醇,通过溶剂蒸发技术改善难溶性药物依托昔布的溶解度和溶出度。采用溶剂蒸发技术,以乳糖、蔗糖和甘露醇为原料,按不同配比制备了依托昔布固体分散体及其物理混合物。分析了依托昔布固体分散体和物理混合体的收率、药物含量、饱和溶解度和体外溶出度。采用FTIR、XRD和DSC对依托昔布的固体分散体进行了表征。红外光谱分析揭示了不同固体分散体分子间氢键形成的可能性。XRD和DSC研究表明,固体分散技术将结晶型(纯药物型)依托托昔布转化为无定形(固体分散体)依托托昔布。与纯依托昔布及其物理混合物相比,在所有依托昔布固体分散体中观察到依托昔布的水溶性和溶解性。体外溶出研究表明,使用乳糖的固体分散体比使用蔗糖和甘露醇的固体分散体溶解性更好。依托昔布在这些固体分散体中的体外溶出符合Hixson-Crowell模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Formulation development and optimization of fast dissolving tablets of aceclofenac using natural superdisintegrant. Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art. High-amylose sodium carboxymethyl starch matrices: development and characterization of tramadol hydrochloride sustained-release tablets for oral administration. Manilkara zapota (Linn.) Seeds: A Potential Source of Natural Gum. Transdermal nitroglycerin delivery using acrylic matrices: design, formulation, and in vitro characterization.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1